News | Heart Failure | April 12, 2022

Comedian Gilbert Gottfried Dies After Battle With Recurrent Ventricular Tachycardia

In an official statement from his family, Gilbert Gottfried, the comedian with the memorable voice, died today at age 67 reportedly following a long-term illness, Recurrent Ventricular Tachycardia due to Myotonic Dystrophy type II.  

Image of late comedian Gilbert Gottfried from Wikipedia


April 12, 2022 — In an official statement from his family, Gilbert Gottfried, the comedian with the memorable voice, died today at age 67 reportedly following a long-term illness, Recurrent Ventricular Tachycardia due to Myotonic Dystrophy type II.  

Tachycardia refers to a heart rate that’s too fast. Ventricular tachycardia is a fast heart rate that starts in the heart’s lower chambers (ventricles). This type of arrhythmia may be either well-tolerated or life-threatening, requiring immediate diagnosis and treatment.

According to the NIH, "Myotonic dystrophy type 2, one of the two types of myotonic dystrophy, is an inherited muscular dystrophy that affects the muscles and other body systems (e.g., heart, eyes, and pancreas)."

For more information: www.heart.org


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now